RONALD PALM: Open Payments
NPI 1326174301 · KEIZER, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 17 payments from 8 companies in 2025. Trend: 2023 $422 · 2024 $418 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $101 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| ABBVIE INC. | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
Products named: REXULTI, FARXIGA, AIRSUPRA, VRAYLAR, Kerendia, SPRAVATO, BREZTRI, The Cologuard Plus Collection Kit.
Industry payments across OR — which companies pay providers there.
